Publications
We’ve partnered with leading brands and research institutions to deliver peer-reviewed clinical trials that advance gut health science. Explore our published work and see how robust evidence can power your product claims.
Supplements
Novel bioactives for gut barrier function in IBS-D
Overview:
The study investigated two bioactive compounds (NCT & NFT), that had been selected by novel AI technology, as compounds with potential benefit to health. Preclinical work had previously shown the compounds to have anti-inflammatory and gut-barrier enhancing properties. Given growing evidence linking irritable bowel syndrome to increased gut permeability, this trial assessed the effect of these compounds on gut barrier integrity and symptoms in patients with IBS-D.
Participants: 32
Medicine
The efficacy of a structured alginate regime prior to reflux testing
Overview:
The study aimed to assess whether structured use of alginates during the PPI wash-out period could reduce symptom burden and improve adherence.
Participants: 60
Supplements
The effect of 14-strain probiotic in healthy volunteers
Overview:
This study aimed to evaluate both compositional and functional changes in the faecal microbiome following 8 weeks of supplementation with a 14-strain probiotic blend.
Participants: 41
Medicine
Assessing changes in colonic physiology in IBS-C patients treated with Linaclotide
Overview:
This study aimed to investigate how linaclotide affects cecal pH, colonic transit, and motility, and how these physiological changes relate to symptom improvement and quality of life in IBS-C patients.
Participants: 13
Supplements
The effect of ERME™ (enzyme-rich malt extract) in adults with chronic constipation
Overview:
This study aimed to evaluate whether 4 weeks of ERME™ supplementation could improve constipation severity, stool form, and GI symptoms in adults with chronic constipation.
Participants: 20
© Copyright The Functional Gut Group 2026